Israel -
Tiếng Do Thái -
Ministry of Health
פירידוסטיגמין 30
rafa laboratories ltd - pyridostigmine bromide - טבליה - pyridostigmine bromide 30 mg - pyridostigmine - pyridostigmine - pyridostigmine belongs to the cholinesterase inhibitor group and is indicated for the treatment of myasthenia gravis.
Israel -
Tiếng Do Thái -
Ministry of Health
פירידוסטיגמין 60
rafa laboratories ltd - pyridostigmine bromide - טבליה - pyridostigmine bromide 60 mg - pyridostigmine - pyridostigmine - pyridostigmine belons to the cholinesterase inhibitor group and is indicated for the treatment of myasthenia gravis.
Israel -
Tiếng Do Thái -
Ministry of Health
מסטינון מחפיות 60 מג
megapharm ltd - pyridostigmine bromide - דרז'ה - pyridostigmine bromide 60.0 mg - pyridostigmine - pyridostigmine - treatment of myasthenia gravis.
Israel -
Tiếng Do Thái -
Ministry of Health
אקסלון 1.5 מג
novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 1.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.
Israel -
Tiếng Do Thái -
Ministry of Health
אקסלון 3 מג
novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 3 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.
Israel -
Tiếng Do Thái -
Ministry of Health
אקסלון 4.5 מג
novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 4.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementiasymptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.
Israel -
Tiếng Do Thái -
Ministry of Health
אקסלון 6 מג
novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 6 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.
Israel -
Tiếng Do Thái -
Ministry of Health
אקסלון מדבקה 10
novartis israel ltd - rivastigmine - מדבקות - rivastigmine 9.5 mg/day - rivastigmine
Israel -
Tiếng Do Thái -
Ministry of Health
אקסלון מדבקה 15
novartis israel ltd - rivastigmine - מדבקות - rivastigmine 27 mg - rivastigmine
Israel -
Tiếng Do Thái -
Ministry of Health
אקסלון מדבקה 5
novartis israel ltd - rivastigmine - מדבקות - rivastigmine 4.6 mg/day - rivastigmine